Skip to main content

Glazer Capital, LLC

SEC CIK
0001076809
Latest filing
Aug 14, 2026

APGE holding history

Apogee Therapeutics, Inc. in every 13F filed by Glazer Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APGE overviewAll 13F holders of APGEFull Q2 2026 holdings

Shares (Q2 2026)
1,641,042
Value
$217.8M
% of portfolio
5.4%
Quarters held
1
Since Q2 2026
Holdings of APGE by Glazer Capital, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,641,042$217.8M5.4%+1,641,042NewHolders